DK272985D0 - Antitumor antibiotikum - Google Patents

Antitumor antibiotikum

Info

Publication number
DK272985D0
DK272985D0 DK272985A DK272985A DK272985D0 DK 272985 D0 DK272985 D0 DK 272985D0 DK 272985 A DK272985 A DK 272985A DK 272985 A DK272985 A DK 272985A DK 272985 D0 DK272985 D0 DK 272985D0
Authority
DK
Denmark
Prior art keywords
antitumor antibiotics
antitumor
antibiotics
Prior art date
Application number
DK272985A
Other languages
English (en)
Other versions
DK272985A (da
Inventor
James A Matson
James A Bush
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK272985D0 publication Critical patent/DK272985D0/da
Publication of DK272985A publication Critical patent/DK272985A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK272985A 1984-06-18 1985-06-17 Antitumor antibiotikum DK272985A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/621,641 US4582639A (en) 1984-06-18 1984-06-18 Antitumor antibiotic compound

Publications (2)

Publication Number Publication Date
DK272985D0 true DK272985D0 (da) 1985-06-17
DK272985A DK272985A (da) 1985-12-19

Family

ID=24491001

Family Applications (1)

Application Number Title Priority Date Filing Date
DK272985A DK272985A (da) 1984-06-18 1985-06-17 Antitumor antibiotikum

Country Status (23)

Country Link
US (1) US4582639A (da)
JP (1) JPS6122099A (da)
KR (1) KR930003107B1 (da)
AT (1) AT395860B (da)
AU (1) AU584075B2 (da)
BE (1) BE902670A (da)
CA (1) CA1230568A (da)
CH (1) CH668974A5 (da)
DE (1) DE3521436A1 (da)
DK (1) DK272985A (da)
ES (1) ES8609485A1 (da)
FI (1) FI80475C (da)
FR (1) FR2568892B1 (da)
GB (1) GB2160529B (da)
GR (1) GR851452B (da)
IE (1) IE58629B1 (da)
IT (1) IT1191622B (da)
LU (1) LU85953A1 (da)
MY (1) MY100478A (da)
NL (1) NL8501708A (da)
PT (1) PT80656B (da)
SE (1) SE464524B (da)
ZA (1) ZA852370B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902781A (en) * 1987-11-24 1990-02-20 Taisho Pharmaceutical Co., Ltd. Novel tripetide derivatives
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung
US5516676A (en) * 1993-06-15 1996-05-14 Bristol-Myers Squibb Company Preparation of C-13 hydroxyl-bearing taxanes using nocardioides or a hydrolase isolated therefrom
US5523219A (en) * 1993-06-15 1996-06-04 Bristol-Myers Squibb Company Enzymatic hydrolysis method for the preparation of C-10 hydroxyl-bearing taxanes and enzymatic esterification method for the preparation of C-10 acyloxy-bearing
US5643871A (en) * 1993-11-23 1997-07-01 Bristol-Meyers Squibb Company Antitumor antibiotics
US5444043A (en) * 1994-02-18 1995-08-22 The Regents Of The University Of California Cyclic heptapeptide anti-inflammatory agent
GB2294265A (en) * 1994-10-20 1996-04-24 Merck & Co Inc Cyclic depsipeptides obtained from Actinomycete sp.
US6329497B1 (en) * 1997-03-28 2001-12-11 The Scripps Research Institute Sandramycin analogs
US6001815A (en) * 1997-12-25 1999-12-14 Nisshin Flour Milling Co., Ltd. Depsipeptides containing N-substituted glycine residue
KR100575681B1 (ko) 2004-05-18 2006-05-03 엘지전자 주식회사 와인 냉장고의 진동절연 지지장치
JP2009504751A (ja) * 2005-08-19 2009-02-05 アメリカ合衆国 ヒストンデアセチラーゼ阻害薬の局所製剤及びその使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4360458A (en) * 1979-04-02 1982-11-23 Bristol-Myers Company Antitumor antibacterial agents
US4451456A (en) * 1979-04-02 1984-05-29 Bristol-Myers Company Antitumor antibacterial agents

Also Published As

Publication number Publication date
ATA178285A (de) 1992-08-15
NL8501708A (nl) 1986-01-16
GB2160529B (en) 1987-10-07
MY100478A (en) 1990-10-15
JPH0158200B2 (da) 1989-12-11
KR860000382A (ko) 1986-01-28
FR2568892B1 (fr) 1990-02-09
GB2160529A (en) 1985-12-24
SE8502996D0 (sv) 1985-06-17
KR930003107B1 (ko) 1993-04-19
IT8521156A0 (it) 1985-06-14
US4582639A (en) 1986-04-15
DE3521436C2 (da) 1993-08-05
LU85953A1 (fr) 1986-01-24
AU4048085A (en) 1986-01-02
FI852082L (fi) 1985-12-19
BE902670A (fr) 1985-12-17
IE58629B1 (en) 1993-10-20
GB8515256D0 (en) 1985-07-17
FI80475B (fi) 1990-02-28
ES8609485A1 (es) 1986-09-01
FI80475C (fi) 1990-06-11
FR2568892A1 (fr) 1986-02-14
AT395860B (de) 1993-03-25
IT1191622B (it) 1988-03-23
JPS6122099A (ja) 1986-01-30
CA1230568A (en) 1987-12-22
FI852082A0 (fi) 1985-05-24
IE851504L (en) 1985-12-18
DE3521436A1 (de) 1985-12-19
PT80656B (pt) 1988-01-22
PT80656A (en) 1985-07-01
AU584075B2 (en) 1989-05-18
ES544289A0 (es) 1986-09-01
DK272985A (da) 1985-12-19
GR851452B (da) 1985-11-25
ZA852370B (en) 1985-11-27
SE464524B (sv) 1991-05-06
SE8502996L (sv) 1985-12-19
CH668974A5 (de) 1989-02-15

Similar Documents

Publication Publication Date Title
DK418085A (da) Antibiotika
DK196586D0 (da) Makrolidantibiotika
AT380762B (de) Hoergeraet
AT379929B (de) Hoergeraet
DK17685D0 (da) Glycosidderivater
ES296062Y (es) Disposicion de acristalado
DK100886D0 (da) Antibiotiske clathrater
IT1157330B (it) Antibiotici diossi-imminocefalosporinici
SE8500011D0 (sv) Cefalosporinantibiotika
DK272985A (da) Antitumor antibiotikum
ATA135485A (de) Maishaecksler
GB8520775D0 (en) Antibiotics
DK500285D0 (da) Cephalosporinantibiotika
AT386724B (de) Haecksler
ATA237384A (de) Maehwerk
ATE86992T1 (de) 1-carbacephalosporin-antibiotika.
PT80487B (pt) Portador de painel
DK327486D0 (da) Loddekop-forbindelsesorgan
SE8205992D0 (sv) Antibiotika
AT389296B (de) Elektrokoagulator
IT1173993B (it) Antibiotico cepacin
IL93419A (en) Antitumor antibiotics ll-e33288beta-i
DK160879C (da) Anthracyclinantibiotika
DE3586120D1 (de) Polyaether-antibiotikum-a80190.
SE8405602D0 (sv) N-festet

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment